Promino Announces Proposed Private Placement

Executive Summary

• Promino Nutritional Sciences Inc. announced a non‑brokered private placement to raise up to $1,200,000 by issuing 40,000,000 units at $0.03 per unit.
• Each unit consists of one common share and half of a warrant exercisable at $0.06 per share for twelve months.
• Net proceeds are earmarked for inventory production and general corporate purposes (excluding accrued officer/director salaries and investor‑relations activities).

Key Details

• Offering Size: Up to $1,200,000 gross proceeds.
• Units Offered: Up to 40,000,000 units at $0.03 per unit.
• Unit Composition: 1 common share + ½ warrant (full warrant = right to purchase 1 additional share at $0.06).
• Warrant Term: Exercisable for twelve (12) months from issuance date.
• Use of Proceeds:
• Invest in inventory production.
• General corporate purposes (excluding accrued salaries to officers/directors and investor‑relations activities).
• Closing Date: Expected on or about April 15, 2026 subject to subscription agreements and regulatory approvals.
• Regulatory Conditions: Requires approval of the Canadian Securities Exchange and other necessary regulatory clearances.
• Resale Restriction: All securities subject to a four‑month‑and‑one‑day statutory resale restriction under Canadian law.
• Finder’s Fees: Company may pay finder’s fees in connection with the offering, as permitted by applicable securities laws and CSE rules.
• U.S. Offering Restrictions: Securities not registered under U.S. securities laws; cannot be offered or sold to U.S. persons absent exemption.

Notable Quotes

(No executive quotes were included in the release.)